ATEC vs. LMAT, LMNX, GNMK, MDXG, KIDS, ITGR, IART, ATRC, SRDX, and OFIX
Should you be buying Alphatec stock or one of its competitors? The main competitors of Alphatec include LeMaitre Vascular (LMAT), Luminex (LMNX), GenMark Diagnostics (GNMK), MiMedx Group (MDXG), OrthoPediatrics (KIDS), Integer (ITGR), Integra LifeSciences (IART), AtriCure (ATRC), Surmodics (SRDX), and Orthofix Medical (OFIX). These companies are all part of the "medical" sector.
LeMaitre Vascular (NASDAQ:LMAT) and Alphatec (NASDAQ:ATEC) are both small-cap medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their earnings, risk, institutional ownership, community ranking, dividends, profitability, valuation, media sentiment and analyst recommendations.
LeMaitre Vascular has a net margin of 16.99% compared to LeMaitre Vascular's net margin of -37.45%. Alphatec's return on equity of 11.57% beat LeMaitre Vascular's return on equity.
LeMaitre Vascular has a beta of 0.89, indicating that its stock price is 11% less volatile than the S&P 500. Comparatively, Alphatec has a beta of 1.41, indicating that its stock price is 41% more volatile than the S&P 500.
84.6% of LeMaitre Vascular shares are owned by institutional investors. Comparatively, 66.4% of Alphatec shares are owned by institutional investors. 10.8% of LeMaitre Vascular shares are owned by insiders. Comparatively, 22.8% of Alphatec shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.
LeMaitre Vascular received 189 more outperform votes than Alphatec when rated by MarketBeat users. Likewise, 70.94% of users gave LeMaitre Vascular an outperform vote while only 56.68% of users gave Alphatec an outperform vote.
LeMaitre Vascular has higher earnings, but lower revenue than Alphatec. Alphatec is trading at a lower price-to-earnings ratio than LeMaitre Vascular, indicating that it is currently the more affordable of the two stocks.
In the previous week, LeMaitre Vascular had 5 more articles in the media than Alphatec. MarketBeat recorded 7 mentions for LeMaitre Vascular and 2 mentions for Alphatec. LeMaitre Vascular's average media sentiment score of 1.77 beat Alphatec's score of 1.03 indicating that Alphatec is being referred to more favorably in the news media.
LeMaitre Vascular presently has a consensus target price of $77.57, indicating a potential upside of 0.12%. Alphatec has a consensus target price of $22.89, indicating a potential upside of 122.44%. Given LeMaitre Vascular's stronger consensus rating and higher probable upside, analysts plainly believe Alphatec is more favorable than LeMaitre Vascular.
Summary
LeMaitre Vascular beats Alphatec on 12 of the 19 factors compared between the two stocks.
Get Alphatec News Delivered to You Automatically
Sign up to receive the latest news and ratings for ATEC and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding ATEC and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Alphatec Competitors List
Related Companies and Tools
